VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability
-
* Corresponding author: Laurence Briant laurence.briant@univ-montp1.fr
1 Université Montpellier 1, Centre d'études d'agents Pathogènes et Biotechnologies pour la Santé (CPBS), France
2 CNRS, UMR 5236, CPBS, F-34965, Montpellier, France
3 Université Montpellier 2, CPBS, F-34095, Montpellier, France
4 GENETHON, 1bis rue de l'Internationale – BP60, 91002 EVRY cedex, France
Retrovirology 2008, 5:57 doi:10.1186/1742-4690-5-57
Published: 7 July 2008Additional files
Additional file 1:
Infectivity of increasing amounts of WT viruses and CA mutants expressing HIV Env or VSV-G. Viral inputs were normalized according to RTase activity (ranging from 100 to 10,000 cpm) and used to infect MAGIC-5B cells. 48 hours post-infection, relative infectivity was measured by quantification of o-nitrophenyl β-D-galactopyranoside hydrolysis. Time of incubation used for revelation of β-galactosidase assay was adapted to produce non saturating OD at 405 nm (1h45 in panel A and 25 min in panel B). For each dose tested, infectivity of S149A and S178A mutants is indicated as a percentage of β-galactosidase activity generated by an identical amount of WT viruses with the corresponding envelope.
Format: PDF Size: 1.2MB Download file
This file can be viewed with: Adobe Acrobat Reader
Additional file 2:
Quantification of β-galactosidase activities generated in MAGIC-5B cells infected with amounts of CA mutants expressing HIV Env or VSV-G that generated comparable strong-stop DNA copy numbers. MAGIC-5B cells were infected with S149A or S178A mutants expressing HIV Env or VSV-G, using infectious doses that generated similar strong-stop DNA copy numbers as measured by qPCR 24 h post-infection. Relative infectivity is expressed as o-nitrophenyl β-D-galactopyranoside hydrolysis measured from total cell extracts by absorbance at 405 nm. Each value represents an average of two experiments performed in duplicate ± standard deviation.
Format: PDF Size: 1.2MB Download file
This file can be viewed with: Adobe Acrobat Reader
